Methylphenidate Hydrochloride Tablet, Extended Release
Product Images NDC 57664-607

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Methylphenidate Hydrochloride (NDC 57664-607). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Methylphenidate 01)

FDA Label Image

Figure 1 (Methylphenidate 02)

This text appears to be a medication label for Methylphenidate Hydrochloride Extended-Release Tablets. The tablets are available in 18 mg strength, and the recommended dosage is 5 mg three times a day. The rest of the text appears to be a graph or chart showing the plasma concentration of the medication over time. However, some of the characters in the graph are not readable, so it is difficult to provide a more specific description.*

FDA Label Image

Figure 2 (Methylphenidate 03)

This is a brief summary of a clinical trial investigating the effectiveness of Methylphenidate Hydrochloride Extended-Release tablets in treating inattention and overactivity. The trial involved three different stages, and the provided text only presents results from "Study 1" at "Week 4." There is also a chart showing the number of symptoms reported in the trial.*

FDA Label Image

Figure 3 (Methylphenidate 04)

FDA Label Image

Pdp-18mg (Methylphenidate 05)

FDA Label Image

Pdp-27mg (Methylphenidate 06)

FDA Label Image

Pdp-36mg (Methylphenidate 07)

Not available.*

FDA Label Image

Pdp-54mg (Methylphenidate 08)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.